drugset / Trial / NCT07597200
A Clinical Study of Cizutamig in Thyroid Eye Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, PK, PD, immunogenicity, and preliminary clinical activity of cizutamig in patients with thyroid eye disease (TED).
Timeline
- Start
- 2026-05-08
- Primary completion
- 2028-05-31
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cizutamig | Protein / enzyme biologic | — | — |